Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-11-23 Sale | 2022-11-28 7:30 pm | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 20,000 | $30.48 | $609,600 | 2,107,225 (Indirect Direct) | View |
| 2022-11-01 Sale | 2022-11-03 5:37 pm | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 20,000 | $30.27 | $605,463 | 2,127,225 (Indirect Direct) | View |
| 2022-09-29 Sale | 2022-10-03 4:05 pm | REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director | 10,838 | $702.24 | $7,610,844 | 12,921 (Direct) | View |
| 2022-09-28 Sale | 2022-09-30 4:50 pm | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 20,000 | $30.82 | $616,304 | 2,147,225 (Indirect Direct) | View |
| 2022-08-23 Sale | 2022-08-25 6:11 pm | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 20,000 | $31.61 | $632,282 | 2,167,225 (Indirect Direct) | View |
| 2022-07-25 Sale | 2022-07-27 6:49 pm | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 20,000 | $35.61 | $712,110 | 2,187,225 (Indirect Direct) | View |
| 2022-03-23 Sale(A) | 2022-06-28 3:07 pm | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 20,000 | $33.83 | $676,583 | 2,261,239 (Indirect Direct) | View |
| 2022-03-23 Sale | 2022-03-25 5:57 pm | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 20,000 | $33.83 | $676,583 | 2,261,239 (Indirect Direct) | View |
| 2022-03-21 Sale | 2022-03-23 4:01 pm | REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director | 7,439 | $690 | $5,132,910 | 2,269 (Direct) | View |
| 2022-03-16 Sale | 2022-03-18 4:05 pm | REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director | 12,191 | $678.21 | $8,268,075 | 2,269 (Direct) | View |
| 2021-12-28 Sale | 2021-12-30 9:59 pm | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 63,131 | $44.43 | $2,805,197 | 2,323,218 (Indirect Direct) | View |
| 2021-12-09 Sale | 2021-12-10 5:41 pm | REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director | 3,784 | $665 | $2,516,360 | 2,078 (Direct) | View |
| 2021-09-13 Sale | 2021-09-15 4:02 pm | REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director | 12,750 | $641.71 | $8,181,827 | 14,828 (Direct) | View |
| 2021-06-07 Sale | 2021-06-08 5:10 pm | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 94,378 | $70.35 | $6,639,523 | 2,552,232 (Direct) | View |
| 2021-05-21 Sale | 2021-05-24 8:05 pm | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 46,763 | $60.11 | $2,811,048 | 2,542,296 (Direct) | View |
| 2021-05-03 Sale | 2021-05-05 4:14 pm | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 3,237 | $60.11 | $194,589 | 2,589,059 (Direct) | View |
| 2021-04-01 Sale | 2021-04-05 4:10 pm | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 50,000 | $56.62 | $2,831,071 | 2,592,296 (Direct) | View |
| 2021-03-01 Sale | 2021-03-03 4:20 pm | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 100,000 | $66.22 | $6,622,207 | 2,642,296 (Direct) | View |
| 2020-06-16 Sale | 2020-06-18 9:41 pm | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 400,000 | $26.1 | $10,440,000 | 2,739,043 (Direct) | View |
| 2020-05-06 Sale | 2020-05-08 4:03 pm | REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director | 15,000 | $563.97 | $8,459,496 | 1,830 (Direct) | View |
| 2020-02-13 Sale | 2020-02-14 4:10 pm | REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director | 14,279 | $400.01 | $5,711,711 | 1,830 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-31 Option Award | 2024-06-04 6:31 pm | N/A 2034-05-31 | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 23,868 | $0 | 2,135,309 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 6:06 pm | N/A 2033-06-01 | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 16,865 | $0 | 2,124,090 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 4:16 pm | N/A 2033-01-03 | REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director | 2,094 | $0 | 4,363 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 4:16 pm | N/A 2033-01-03 | REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director | 2,094 | $0 | 4,363 (Direct) | View |
| 2022-09-29 Exercise | 2022-10-03 4:05 pm | N/A 2025-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director | 10,838 | $0 | 12,921 (Direct) | View |
| 2022-09-29 Exercise | 2022-10-03 4:05 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director | 10,838 | $413.33 | 12,921 (Direct) | View |
| 2022-06-23 Disposition | 2022-06-27 8:54 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 13,250 | $31.1 | 2,207,225 (Direct) | View |
| 2022-06-24 Disposition | 2022-06-27 8:54 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 39,984 | $30.53 | 2,207,225 (Direct) | View |
| 2022-06-24 Disposition | 2022-06-27 8:54 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 6,766 | $31.08 | 2,207,225 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-06 8:09 pm | N/A 2032-06-02 | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 23,945 | $0 | 2,285,184 (Direct) | View |
| 2022-03-21 Exercise | 2022-03-23 4:01 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director | 7,439 | $380.95 | 2,269 (Direct) | View |
| 2022-03-21 Exercise | 2022-03-23 4:01 pm | N/A 2028-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director | 7,439 | $0 | 2,269 (Direct) | View |
| 2022-03-17 Exercise | 2022-03-18 4:05 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director | 7,830 | $376.69 | 2,269 (Direct) | View |
| 2022-03-16 Exercise | 2022-03-18 4:05 pm | N/A 2030-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director | 12,191 | $0 | 2,269 (Direct) | View |
| 2022-03-16 Exercise | 2022-03-18 4:05 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director | 4,361 | $374.12 | 2,269 (Direct) | View |
Ownership | 2022-02-17 8:25 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 0 | $0 | 2,281,239 (Indirect) | View |
| 2021-12-13 Ownership | 2022-02-17 8:25 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 200,000 | $0 | 2,281,239 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 4:23 pm | N/A 2032-01-03 | REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director | 2,898 | $0 | 4,976 (Direct) | View |
| 2021-10-04 Gift | 2021-12-30 9:59 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 400,000 | $0 | 2,323,218 (Direct) | View |
| 2021-12-09 Exercise | 2021-12-10 5:41 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director | 3,784 | $371.4 | 2,078 (Direct) | View |
| 2021-12-09 Exercise | 2021-12-10 5:41 pm | N/A 2029-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director | 3,784 | $0 | 2,078 (Direct) | View |
| 2021-09-13 Exercise | 2021-09-15 4:02 pm | N/A 2024-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director | 12,750 | $0 | 14,828 (Direct) | View |
| 2021-09-13 Exercise | 2021-09-15 4:02 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director | 4,250 | $273.67 | 14,828 (Direct) | View |
| 2021-06-07 Exercise | 2021-06-08 5:10 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 27,245 | $19.5 | 2,552,232 (Direct) | View |
| 2021-06-07 Exercise | 2021-06-08 5:10 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 39,303 | $18 | 2,552,232 (Direct) | View |
| 2021-06-07 Exercise | 2021-06-08 5:10 pm | N/A 2027-12-07 | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 94,378 | $0 | 2,552,232 (Direct) | View |
| 2021-06-07 Exercise | 2021-06-08 5:10 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 27,830 | $18.92 | 2,552,232 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 6:37 pm | N/A 2031-06-02 | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 8,296 | $0 | 2,550,592 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-05 4:11 pm | N/A 2031-01-04 | REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director | 3,861 | $0 | 5,691 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:00 pm | N/A 2030-06-02 | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 18,436 | $0 | 18,436 (Direct) | View |
| 2020-05-06 Exercise | 2020-05-08 4:03 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director | 15,000 | $177.82 | 1,830 (Direct) | View |
| 2020-05-06 Exercise | 2020-05-08 4:03 pm | N/A 2023-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director | 15,000 | $0 | 1,830 (Direct) | View |
| 2020-02-13 Exercise | 2020-02-14 4:10 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director | 9,279 | $50.91 | 1,830 (Direct) | View |
| 2020-02-13 Exercise | 2020-02-14 4:10 pm | N/A 2021-11-18 | REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director | 14,279 | $0 | 1,830 (Direct) | View |
| 2020-02-13 Exercise | 2020-02-14 4:10 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director | 5,000 | $57.11 | 1,830 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-06 4:07 pm | N/A 2030-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director | 4,681 | $0 | 6,191 (Direct) | View |